Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | HTR5A | P47898 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | DKK1 | O94907 | 2/20 | 0.36 |
| ▸ | F2 | P00734 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13759498 | 0.92 | HTR2B (0.44) | HTR2BHTR5ACYP11B1CYP11B2NPY5R | |
| SCHEMBL13759456 | 0.90 | HTR2B (0.41) | HTR2BHTR5ACYP11B1CYP11B2NPY5R | |
| SCHEMBL13759457 | 0.89 | HTR2B (0.43) | HTR2BHTR5ACYP11B1CYP11B2NPY5R | |
| SCHEMBL15977567 | 0.88 | HTR2B (0.50) | HTR2BHTR5ACYP11B1CYP11B2NPY5R | |
| SCHEMBL13759484 | 0.87 | HTR2B (0.44) | HTR2BHTR5ACYP11B1CYP11B2NPY5R | |
| SCHEMBL12571766 | 0.87 | HTR2B (0.48) | HTR2BHTR5ACYP11B1CYP11B2NPY5R | |
| SCHEMBL15977440 | 0.86 | HTR2B (0.48) | HTR2BHTR5ACYP11B1CYP11B2NPY5R | |
| SCHEMBL19978490 | 0.86 | CYP11B1 (0.44) | CYP11B1CYP11B2MAPTKDM4ENPC1 | |
| SCHEMBL13759458 | 0.84 | HTR2B (0.41) | HTR2BHTR5ANPY5RMAPTKDM4E | |
| SCHEMBL15977693 | 0.84 | SMN1; SMN2 (0.45) | CYP11B1CYP11B2MAPTKDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8367220-B2 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-02-05 | — | — | US | disclosed |
| US-8367220-B2 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-02-05 | — | — | US | disclosed |
| US-20090166670-A1 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-07-02 | — | — | US | disclosed |
| US-20090166670-A1 | Anthracene-based compound and organic light emitting device employing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090166670-A1 | Anthracene-based compound and organic light emitting device employing the same | CCNL2, CRY2, ATXN2L | HTR2B 2548/4885HTR5A 4554/4885CYP11B1 1455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.